Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Frequently asked questions
What sector does Fractyl Health, Inc. Common Stock (GUTS) operate in?
Fractyl Health, Inc. Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Fractyl Health, Inc. Common Stock (GUTS) current stock price?
As of the latest data, Fractyl Health, Inc. Common Stock stock price is $0.87, with a previous close of $1.07. Fractyl Health, Inc. Common Stock lost -$0.20 in the last trading session, representing a -18.69% loss.
What is Fractyl Health, Inc. Common Stock (GUTS) current market capitalization?
Fractyl Health, Inc. Common Stock market cap is approximately 11.54 million.
What is Fractyl Health, Inc. Common Stock (GUTS) Earnings Per Share (EPS)?
The trailing EPS is -$10.56, and the forward EPS is -$0.69.
What is Fractyl Health, Inc. Common Stock (GUTS) EBITDA?
Fractyl Health, Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -25.26 million.
Does Fractyl Health, Inc. Common Stock (GUTS) pay dividends?
No. Fractyl Health, Inc. Common Stock does not pay a dividend.
When is Fractyl Health, Inc. Common Stock (GUTS) next earnings report?
Fractyl Health, Inc. Common Stock is expected to release its next earnings report on September 30, 2026.
What is Fractyl Health, Inc. Common Stock (GUTS) beta (volatility) score?
Fractyl Health, Inc. Common Stock has a beta of 2.415, indicating very high volatility compared to the market.
